HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Achievement of complete mycological cure by topical antifungal agent NND-502 in guinea pig model of tinea pedis.

Abstract
We examined the therapeutic effect of a 1% cream preparation of NND-502, a novel topical antifungal agent, in a guinea pig tinea pedis model produced by infecting the plantar skin of guinea pigs with Trichophyton mentagrophytes. Animals developing tinea pedis were divided into two groups: an untreated control group and a treated group. In the latter group, after confirming infection had been established, the infected animals were topically treated with the NND-502 cream once daily for one week. The animals were reared in a clean environment free from exposure to exogenous dermatophytes. At one week (5 weeks post-infection), 6 weeks (10 weeks post-infection) and 16 weeks (20 weeks post-infection) after completion of the treatment, plantar skin samples were taken from a certain number of both groups of animals. The results demonstrated that all of the animals in the untreated control group and none of those in the treated group were culture-positive in this animal model of tinea pedis. The topical treatment with NND-502 achieved a mycological cure. Thus NND-502 can be considered a promising candidate as a new anti-dermatophytic agent for topical use.
AuthorsKatsuhisa Uchida, Takashi Tanaka, Hideyo Yamaguchi
JournalMicrobiology and immunology (Microbiol Immunol) Vol. 47 Issue 2 Pg. 143-6 ( 2003) ISSN: 0385-5600 [Print] Australia
PMID12680717 (Publication Type: Journal Article)
Chemical References
  • Antifungal Agents
  • Culture Media
  • Imidazoles
  • luliconazole
Topics
  • Administration, Topical
  • Animals
  • Antifungal Agents (therapeutic use)
  • Culture Media
  • Disease Models, Animal
  • Female
  • Guinea Pigs
  • Imidazoles (therapeutic use)
  • Skin (microbiology)
  • Tinea Pedis (drug therapy, microbiology)
  • Treatment Outcome
  • Trichophyton (drug effects, growth & development, pathogenicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: